Neuroscience Antibodies and Assays Market size to grow by USD 1,837.68 million from 2022 to 2027|Increasing incidences of neurological disorders is one of the key drivers- Technavio

NEW YORK, July 4, 2023 /PRNewswire/ -- The neuroscience antibodies and assays market size is estimated to grow by USD 1,837.68 million from 2022  to 2027, according to Technavio. The market is estimated to grow at a CAGR of 9.44%. The growth momentum will progress during the forecast period. North America is projected to account for 46%  of growth during the forecast period. The growing demand for the diagnosis of neurological disorders has stimulated the demand for neuroscience antibodies and assays. For instance, in March 2021, an estimated 6.2 million Americans aged 65 years and older were living with Alzheimer's Disease and dementia. This number could rise to 13.8 million by 2060. Therefore, the high majority of neurological disorders, the rising aging population, high healthcare expenditure on treating neurological diseases, and favorable reimbursement policies for neuro-diagnostic procedures are expected to fuel the market growth during the forecast period. For more insights on the historic period (2017 to 2021) and forecast market size (2023 to 2027) - Request a sample report

What's New?

• Special coverage on the Russia-Ukraine war; global inflation; recovery analysis from COVID-19; supply chain disruptions, global trade tensions; and risk of recession 
• Global competitiveness and key competitor positions 
• Market presence across multiple geographical footprints - Strong/Active/Niche/Trivial  - buy the report!

Neuroscience Antibodies And Assays Market - Segmentation Assessment
Segment Overview
Technavio has segmented the market based on the product (Consumables and Instruments), end-user (Pharmaceutical and biopharmaceutical companies, Academic and research institutes, and Hospital and diagnostic centres), and geography (North America, Europe, Asia, and the Rest of the World (ROW)). 

• The market share growth by the consumables segment will be significant during the forecast period. A broad range of antibodies, assay kits, and reagents are used in neuroscience assays to find new disease targets, deliver high-throughput screening of clinical compounds, comprehend the mechanism of action, and generate clinically relevant biomarkers. Generally, there are two types of consumables, namely Antibodies and Assay kits, and reagents. Due to the discovery of new potential drug targets, signaling molecules, and structural proteins in the brain, the demand for neuroscience antibodies, antigens, assay kits, and reagents has significantly increased. Also, the growing importance of neuroscience processes and neurodegenerative diseases research and the broad availability of antibodies, assay kits, and reagents will fuel the growth of the consumables segment during the forecast period.

Insights on the market contribution of various segments, including country and region-wise historic data (2017 to 2021), and forecast market size (2023 to 2027) - Download a Sample Report

Neuroscience Antibodies and Assays Market – Market Dynamics
Key factor driving market growth

Increasing incidences of neurological disorders notably drive the neuroscience antibodies and assay market growth. Patients with a broad range of neurological disorders, including epilepsy, stroke, PD, and brain tumors, have a high risk of developing a disability. Among them, PD is one of the most common neurological diseases affecting people. According to the Centers for Disease Control and Prevention (CDC), the majority of PD increases from 1% to 4% in the aging population of 60 years to 80 years. Among the geriatric population, the majority of the disease is more common. For instance, In India, stroke, headache disorders, and epilepsy are the highest contributors to neurological disorders burden. Therefore, factors such as the growing incidence and majority of different neurological disorders and the rising demand for treating such disorders to save patients' lives will account for the growth of the global neuroscience antibodies and assays market during the forecast period. Furthermore, treating brain hemorrhage due to stroke and brain tumors is driving the demand for neuroscience antibodies and assays. A stroke can lead to malignant cerebral edema, which leads to inadequate blood flow in September 2021. This increases intracranial pressure and brain shift, causing herniation syndrome and leading to brain death. Such cases add to the demand for the diagnosis of brain injuries. Therefore, the growth in the number of stroke cases is anticipated to drive the growth of the market in focus during the forecast period.

Major challenge hindering the market growth

The high cost of neuroscience antibodies is impeding neuroscience antibodies and assay market growth. Neuroscience antibodies' development cost is notably high and often not compensated for by their sales revenue which is hindering market growth. The average development cost can range from a few thousand to tens of thousands of dollars, depending on the antibody type. Generally, monoclonal antibodies are the costliest to develop. Various vendors struggle to develop effective annual sales for their research antibodies due to this high cost, and most commercial research antibodies are still polyclonal ones. Additionally, due to the high development cost, some manufacturers forego extensive quality control of their research antibodies, directing to poor research publications that require retraction. Therefore, such factors are expected to hinder the market growth during the forecast period.

Insights on Market Drivers, trends, & Challenges, historic period(2017 to 2021) and forecast period(2023 to 2027)- Request a sample report!

What are the key data covered in this Neuroscience Antibodies And Assays Market report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the neuroscience antibodies and assays market between 2023 and 2027
• Precise estimation of the size of the neuroscience antibodies and assays market  size and its contribution to the market in focus on the parent market
• Accurate predictions about upcoming trends and changes in consumer behaviour
• Growth of the neuroscience antibodies and assays market industry across North America, Europe, Asia, and the Rest of the World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information about vendors
• Comprehensive analysis of factors that will challenge the growth of Neuroscience Antibodies And Assays Market vendors

Gain instant access to 17,000+ market research reports. 

Technavio's SUBSCRIPTION platform

Related Reports:

The Global Biologic Therapeutics Market size is estimated to grow at a CAGR of 11.34% between 2022 and 2027. The size of the market is forecast to increase by USD 286.12 billion. This report extensively covers market segmentation by application (cancer, infectious diseases, autoimmune diseases, and others), product (antibody therapeutics, vaccines, cell therapy, gene therapy, and others), and geography (North America, Europe, Asia, and Rest of World (ROW)). The introduction of biosimilars is notably driving the biologic therapeutics market growth. 

The lateral flow assay components market is estimated to grow at a CAGR of 5.22% between 2022 and 2027. The size of the market is forecast to increase by USD 97.76 million. This report extensively covers market segmentation by technique (sandwich assays, competitive assays, and multiplex detection assays), end-user (medical device manufacturing companies and medical device contract manufacturing companies), and geography (North America, Europe, Asia, and the Rest of World (ROW)). The rising efforts in research and development are the key factor driving the global lateral flow assay components market growth.

Table of contents

1 Executive Summary

• 1.1 Market overview 
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem 
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition 
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022 

• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global neuroscience antibodies and assays market 2017 - 2021 
• Exhibit 18: Historic Market Size – Data Table on Global neuroscience antibodies and assays market 2017 - 2021 ($ million)

• 4.2 Product Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 ($ million)

• 4.3 End-user Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size – End-user Segment 2017 - 2021 ($ million)

• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary 
• Exhibit 23: Five forces analysis - Comparison between2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry 
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition 
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product

• 6.1 Market segments 
• Exhibit 30: Chart on Product - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Product - Market share 2022-2027 (%)

• 6.2 Comparison by Product 
• Exhibit 32: Chart on Comparison by Product
• Exhibit 33: Data Table on Comparison by Product

• 6.3 Consumables - Market size and forecast 2022-2027
• Exhibit 34: Chart on Consumables - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Consumables - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Consumables - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Consumables - Year-over-year growth 2022-2027 (%)

• 6.4 Instruments - Market size and forecast 2022-2027
• Exhibit 38: Chart on Instruments - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Instruments - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Instruments - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Instruments - Year-over-year growth 2022-2027 (%)

• 6.5 Market opportunity by Product 
• Exhibit 42: Market opportunity by Product ($ million)

7 Market Segmentation by End-user

• 7.1 Market segments 
• Exhibit 43: Chart on End-user - Market share 2022-2027 (%)
• Exhibit 44: Data Table on End-user - Market share 2022-2027 (%)

• 7.2 Comparison by End-user 
• Exhibit 45: Chart on Comparison by End-user
• Exhibit 46: Data Table on Comparison by End-user

• 7.3 Pharmaceutical and biopharmaceutical companies - Market size and forecast 2022-2027 
• Exhibit 47: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2022-2027 ($ million)
• Exhibit 48: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2022-2027 ($ million)
• Exhibit 49: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2022-2027 (%)
• Exhibit 50: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2022-2027 (%)

• 7.4 Academic and research institutes - Market size and forecast 2022-2027 
• Exhibit 51: Chart on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
• Exhibit 52: Data Table on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Chart on Academic and research institutes - Year-over-year growth 2022-2027 (%)
• Exhibit 54: Data Table on Academic and research institutes - Year-over-year growth 2022-2027 (%)

• 7.5 Hospital and diagnostic centers - Market size and forecast 2022-2027 
• Exhibit 55: Chart on Hospital and diagnostic centers - Market size and forecast 2022-2027 ($ million)
• Exhibit 56: Data Table on Hospital and diagnostic centers - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Chart on Hospital and diagnostic centers - Year-over-year growth 2022-2027 (%)
• Exhibit 58: Data Table on Hospital and diagnostic centers - Year-over-year growth 2022-2027 (%)

• 7.6 Market opportunity by End-user 
• Exhibit 59: Market opportunity by End-user ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 61: Chart on Market share by geography 2022-2027 (%)
• Exhibit 62: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 63: Chart on Geographic comparison
• Exhibit 64: Data Table on Geographic comparison

• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)

• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)

• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 
• Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

• 9.7 US - Market size and forecast 2022-2027
• Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)

• 9.8 Germany - Market size and forecast 2022-2027
• Exhibit 85: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 87: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 88: Data Table on Germany - Year-over-year growth 2022-2027 (%)

• 9.9 China - Market size and forecast 2022-2027
• Exhibit 89: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 90: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 91: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 92: Data Table on China - Year-over-year growth 2022-2027 (%)

• 9.10 UK - Market size and forecast 2022-2027
• Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)

• 9.11 France - Market size and forecast 2022-2027
• Exhibit 97: Chart on France - Market size and forecast 2022-2027 ($ million)
• Exhibit 98: Data Table on France - Market size and forecast 2022-2027 ($ million)
• Exhibit 99: Chart on France - Year-over-year growth 2022-2027 (%)
• Exhibit 100: Data Table on France - Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 101: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers 

• 10.2 Market challenges 

• 10.3 Impact of drivers and challenges 
• Exhibit 102: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends 

11 Vendor Landscape

• 11.1 Overview 

• 11.2 Vendor landscape 
• Exhibit 103: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption 
• Exhibit 104: Overview on factors of disruption

• 11.4 Industry risks 
• Exhibit 105: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered 
• Exhibit 106: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 107: Matrix on vendor position and classification

• 12.3 Abcam plc 
• Exhibit 108: Abcam plc - Overview
• Exhibit 109: Abcam plc - Product / Service
• Exhibit 110: Abcam plc - Key news
• Exhibit 111: Abcam plc - Key offerings

• 12.4 Abnova Corp. 
• Exhibit 112: Abnova Corp. - Overview
• Exhibit 113: Abnova Corp. - Product / Service
• Exhibit 114: Abnova Corp. - Key offerings

• 12.5 ADx NeuroSciences NV 
• Exhibit 115: ADx NeuroSciences NV - Overview
• Exhibit 116: ADx NeuroSciences NV - Product / Service
• Exhibit 117: ADx NeuroSciences NV - Key offerings

• 12.6 Bio Rad Laboratories Inc. 
• Exhibit 118: Bio Rad Laboratories Inc. - Overview
• Exhibit 119: Bio Rad Laboratories Inc. - Business segments
• Exhibit 120: Bio Rad Laboratories Inc. - Key news
• Exhibit 121: Bio Rad Laboratories Inc. - Key offerings
• Exhibit 122: Bio Rad Laboratories Inc. - Segment focus

• 12.7 BMG LABTECH GmbH 
• Exhibit 123: BMG LABTECH GmbH - Overview
• Exhibit 124: BMG LABTECH GmbH - Product / Service
• Exhibit 125: BMG LABTECH GmbH - Key offerings

• 12.8 Cell Signaling Technology Inc. 
• Exhibit 126: Cell Signaling Technology Inc. - Overview
• Exhibit 127: Cell Signaling Technology Inc. - Product / Service
• Exhibit 128: Cell Signaling Technology Inc. - Key offerings

• 12.9 Chemie Brunschwig AG 
• Exhibit 129: Chemie Brunschwig AG - Overview
• Exhibit 130: Chemie Brunschwig AG - Product / Service
• Exhibit 131: Chemie Brunschwig AG - Key offerings

• 12.10 Elabscience Biotechnology Inc. 
• Exhibit 132: Elabscience Biotechnology Inc. - Overview
• Exhibit 133: Elabscience Biotechnology Inc. - Product / Service
• Exhibit 134: Elabscience Biotechnology Inc. - Key offerings

• 12.11 F. Hoffmann La Roche Ltd. 
• Exhibit 135: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 136: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 137: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 138: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 139: F. Hoffmann La Roche Ltd. - Segment focus

• 12.12 GenScript Biotech Corp. 
• Exhibit 140: GenScript Biotech Corp. - Overview
• Exhibit 141: GenScript Biotech Corp. - Business segments
• Exhibit 142: GenScript Biotech Corp. - Key news
• Exhibit 143: GenScript Biotech Corp. - Key offerings
• Exhibit 144: GenScript Biotech Corp. - Segment focus

• 12.13 Merck and Co. Inc. 
• Exhibit 145: Merck and Co. Inc. - Overview
• Exhibit 146: Merck and Co. Inc. - Business segments
• Exhibit 147: Merck and Co. Inc. - Key news
• Exhibit 148: Merck and Co. Inc. - Key offerings
• Exhibit 149: Merck and Co. Inc. - Segment focus

• 12.14 PerkinElmer Inc. 
• Exhibit 150: PerkinElmer Inc. - Overview
• Exhibit 151: PerkinElmer Inc. - Business segments
• Exhibit 152: PerkinElmer Inc. - Key news
• Exhibit 153: PerkinElmer Inc. - Key offerings
• Exhibit 154: PerkinElmer Inc. - Segment focus

• 12.15 Rockland Immunochemicals Inc. 
• Exhibit 155: Rockland Immunochemicals Inc. - Overview
• Exhibit 156: Rockland Immunochemicals Inc. - Product / Service
• Exhibit 157: Rockland Immunochemicals Inc. - Key offerings

• 12.16 Santa Cruz Biotechnology Inc. 
• Exhibit 158: Santa Cruz Biotechnology Inc. - Overview
• Exhibit 159: Santa Cruz Biotechnology Inc. - Product / Service
• Exhibit 160: Santa Cruz Biotechnology Inc. - Key offerings

• 12.17 Thermo Fisher Scientific Inc. 
• Exhibit 161: Thermo Fisher Scientific Inc. - Overview
• Exhibit 162: Thermo Fisher Scientific Inc. - Business segments
• Exhibit 163: Thermo Fisher Scientific Inc. - Key news
• Exhibit 164: Thermo Fisher Scientific Inc. - Key offerings
• Exhibit 165: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report 

• 13.2 Inclusions and exclusions checklist
• Exhibit 166: Inclusions checklist
• Exhibit 167: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 168: Currency conversion rates for US$

• 13.4 Research methodology 
• Exhibit 169: Research methodology
• Exhibit 170: Validation techniques employed for market sizing
• Exhibit 171: Information sources

• 13.5 List of abbreviations 
• Exhibit 172: List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com

SOURCE Technavio

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED